Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06650605
Title Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma (CITADEL-123)
Acronym CITADEL-123
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Theragnostics Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR


No variant requirements are available.